Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Highmark Wholecare | Pharmacogenetic TestingPayerPolicy · HIGHMARK_WHOLECARE-MP-126-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Pathology Testing with Mohs Micrographic SurgeryPayerPolicy · HIGHMARK_WHOLECARE-MP-151-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Passive Oscillatory Devices in the Outpatient SettingPayerPolicy · HIGHMARK_WHOLECARE-MP-029-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Oncologic Genetic Testing PanelsPayerPolicy · HIGHMARK_WHOLECARE-MP-074-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Obstetrical UltrasoundPayerPolicy · HIGHMARK_WHOLECARE-MP-132-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Observation and Inpatient AdmissionsPayerPolicy · HIGHMARK_WHOLECARE-MP-144-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Non-Oncologic Genetic Testing PanelsPayerPolicy · HIGHMARK_WHOLECARE-MP-071-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Negative Pressure Wound Therapy in the Outpatient SettingPayerPolicy · HIGHMARK_WHOLECARE-MP-022-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Nail Disorder Infectious Disease Testing, Including OnychomycosisPayerPolicy · HIGHMARK_WHOLECARE-MP-152-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Myoelectric Upper Extremity OrthosesPayerPolicy · HIGHMARK_WHOLECARE-MP-075-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Multimarker Serum Testing Related to Ovarian CancerPayerPolicy · HIGHMARK_WHOLECARE-MP-108-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Molecular Tumor Markers for Non-Small Cell Lung Cancer (NSCLC)PayerPolicy · HIGHMARK_WHOLECARE-MP-061-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Molecular Markers for Fine Needle Aspirates of Thyroid NodulesPayerPolicy · HIGHMARK_WHOLECARE-MP-065-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Minimally Invasive Lumbar Decompression (MILD)PayerPolicy · HIGHMARK_WHOLECARE-MP-103-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Magnetic Resonance-Guided Focused Ultrasound (MRgFUS)PayerPolicy · HIGHMARK_WHOLECARE-MP-094-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | LymphoscintigraphyPayerPolicy · HIGHMARK_WHOLECARE-MP-139-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Long-Term Acute Care (LTAC)PayerPolicy · HIGHMARK_WHOLECARE-MP-129-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Liver Fibrosis Assessment BiomarkersPayerPolicy · HIGHMARK_WHOLECARE-MP-137-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Laboratory Studies for Diagnosing and Managing Inflammatory Bowel DiseasePayerPolicy · HIGHMARK_WHOLECARE-MP-123-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Intraoperative Neurophysiologic MonitoringPayerPolicy · HIGHMARK_WHOLECARE-MP-130-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Hysterectomy for Benign ConditionsPayerPolicy · HIGHMARK_WHOLECARE-MP-020-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Genetic Testing for Warfarin and Clopidogrel TherapyPayerPolicy · HIGHMARK_WHOLECARE-MP-063-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Genetic Testing for Lynch Syndrome, Familial Adenomatous Polyposis (FAP), Attenuated FAP and MYH-associated PolyposisPayerPolicy · HIGHMARK_WHOLECARE-MP-018-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Genetic Testing for Cystic FibrosisPayerPolicy · HIGHMARK_WHOLECARE-MP-006-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Gene Expression Testing for Cancer Treatment (Breast, Colon, Prostate)PayerPolicy · HIGHMARK_WHOLECARE-MP-005-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Gene Expression and Biomarker Prostate Cancer TestingPayerPolicy · HIGHMARK_WHOLECARE-MP-100-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Gender Affirmation ServicesPayerPolicy · HIGHMARK_WHOLECARE-HMWC-MEDICAID-MEDICAL-MP-033-MD-PA-GENDERAFFIRMATION-APR23-F9918D966C | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Gastrointestinal Pathogen AssaysPayerPolicy · HIGHMARK_WHOLECARE-MP-113-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Fetal Aneuploidy Testing Using Noninvasive Cell-Free Fetal DNAPayerPolicy · HIGHMARK_WHOLECARE-MP-003-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Fecal Microbiota TransplantPayerPolicy · HIGHMARK_WHOLECARE-MP-066-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Face and Ear ProsthesesPayerPolicy · HIGHMARK_WHOLECARE-MP-155-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Experimental/Investigational ServicesPayerPolicy · HIGHMARK_WHOLECARE-MP-118-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Experimental/Investigational Laboratory ServicesPayerPolicy · HIGHMARK_WHOLECARE-MP-121-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Exhaled Nitric Oxide Measurement in the Management of Respiratory DisordersPayerPolicy · HIGHMARK_WHOLECARE-MP-104-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Enteral NutritionPayerPolicy · HIGHMARK_WHOLECARE-MP-147-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Electrical Stimulation for Oropharyngeal DysphagiaPayerPolicy · HIGHMARK_WHOLECARE-MP-099-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Electrical Bone Growth Stimulators (Noninvasive/Invasive, Spinal, & Ultrasound)PayerPolicy · HIGHMARK_WHOLECARE-MP-070-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Dual-Energy X-ray Absorptiometry (DXA) for Vertebral Fracture AssessmentPayerPolicy · HIGHMARK_WHOLECARE-MP-106-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Drug TestingPayerPolicy · HIGHMARK_WHOLECARE-MP-119-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Cosmetic ProceduresPayerPolicy · HIGHMARK_WHOLECARE-MP-082-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Concurrent CarePayerPolicy · HIGHMARK_WHOLECARE-MP-115-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Clinical TrialsPayerPolicy · HIGHMARK_WHOLECARE-MP-117-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Chromosomal Microarray Analysis (CMA): Comparative Genomic Hybridization (CGH) and Single Nucleotide Polymorphism (SNP)PayerPolicy · HIGHMARK_WHOLECARE-MP-012-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Carpal Tunnel SurgeryPayerPolicy · HIGHMARK_WHOLECARE-MP-053-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Cardiovascular Disease Laboratory TestingPayerPolicy · HIGHMARK_WHOLECARE-MP-138-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Cardiac MonitorsPayerPolicy · HIGHMARK_WHOLECARE-MP-136-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Cardiac Contractility Modulation (CCM) TherapyPayerPolicy · HIGHMARK_WHOLECARE-MP-114-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Capsule EndoscopyPayerPolicy · HIGHMARK_WHOLECARE-MP-038-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Bronchial ThermoplastyPayerPolicy · HIGHMARK_WHOLECARE-MP-050-MD-PA | New policy |
|---|
| Aug 2, 2026 | Highmark Wholecare | Breast ScintimammographyPayerPolicy · HIGHMARK_WHOLECARE-MP-105-MD-PA | New policy |
|---|